134 related articles for article (PubMed ID: 29966762)
21. DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in Gastric Cancer Cells.
Tajirika T; Tokumaru Y; Taniguchi K; Sugito N; Matsuhashi N; Futamura M; Yanagihara K; Akao Y; Yoshida K
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987267
[TBL] [Abstract][Full Text] [Related]
22. Identification of DEAD-box RNA helicase 6 (DDX6) as a cellular modulator of vascular endothelial growth factor expression under hypoxia.
de Vries S; Naarmann-de Vries IS; Urlaub H; Lue H; Bernhagen J; Ostareck DH; Ostareck-Lederer A
J Biol Chem; 2013 Feb; 288(8):5815-27. PubMed ID: 23293030
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy.
Smith PY; Delay C; Girard J; Papon MA; Planel E; Sergeant N; Buée L; Hébert SS
Hum Mol Genet; 2011 Oct; 20(20):4016-24. PubMed ID: 21807765
[TBL] [Abstract][Full Text] [Related]
24. DDX6 and its orthologs as modulators of cellular and viral RNA expression.
Ostareck DH; Naarmann-de Vries IS; Ostareck-Lederer A
Wiley Interdiscip Rev RNA; 2014; 5(5):659-78. PubMed ID: 24788243
[TBL] [Abstract][Full Text] [Related]
25. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
26. Mammalian hyperplastic discs homolog EDD regulates miRNA-mediated gene silencing.
Su H; Meng S; Lu Y; Trombly MI; Chen J; Lin C; Turk A; Wang X
Mol Cell; 2011 Jul; 43(1):97-109. PubMed ID: 21726813
[TBL] [Abstract][Full Text] [Related]
27. P-body assembly requires DDX6 repression complexes rather than decay or Ataxin2/2L complexes.
Ayache J; Bénard M; Ernoult-Lange M; Minshall N; Standart N; Kress M; Weil D
Mol Biol Cell; 2015 Jul; 26(14):2579-95. PubMed ID: 25995375
[TBL] [Abstract][Full Text] [Related]
28. DDX6 Helicase Behavior and Protein Partners in Human Adipose Tissue-Derived Stem Cells during Early Adipogenesis and Osteogenesis.
Marcon BH; Rebelatto CK; Cofré AR; Dallagiovanna B; Correa A
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283676
[TBL] [Abstract][Full Text] [Related]
29. Role of p54 RNA helicase activity and its C-terminal domain in translational repression, P-body localization and assembly.
Minshall N; Kress M; Weil D; Standart N
Mol Biol Cell; 2009 May; 20(9):2464-72. PubMed ID: 19297524
[TBL] [Abstract][Full Text] [Related]
30. Dual mechanisms regulate the nucleocytoplasmic localization of human DDX6.
Huang JH; Ku WC; Chen YC; Chang YL; Chu CY
Sci Rep; 2017 Feb; 7():42853. PubMed ID: 28216671
[TBL] [Abstract][Full Text] [Related]
31. Tau pathology in Alzheimer disease and other tauopathies.
Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
[TBL] [Abstract][Full Text] [Related]
32. Rare De Novo Missense Variants in RNA Helicase DDX6 Cause Intellectual Disability and Dysmorphic Features and Lead to P-Body Defects and RNA Dysregulation.
Balak C; Benard M; Schaefer E; Iqbal S; Ramsey K; Ernoult-Lange M; Mattioli F; Llaci L; Geoffroy V; Courel M; Naymik M; Bachman KK; Pfundt R; Rump P; Ter Beest J; Wentzensen IM; Monaghan KG; McWalter K; Richholt R; Le Béchec A; Jepsen W; De Both M; Belnap N; Boland A; Piras IS; Deleuze JF; Szelinger S; Dollfus H; Chelly J; Muller J; Campbell A; Lal D; Rangasamy S; Mandel JL; Narayanan V; Huentelman M; Weil D; Piton A
Am J Hum Genet; 2019 Sep; 105(3):509-525. PubMed ID: 31422817
[TBL] [Abstract][Full Text] [Related]
33. Tau and tauopathies.
Arendt T; Stieler JT; Holzer M
Brain Res Bull; 2016 Sep; 126(Pt 3):238-292. PubMed ID: 27615390
[TBL] [Abstract][Full Text] [Related]
34. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
Brandt R; Hundelt M; Shahani N
Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
[TBL] [Abstract][Full Text] [Related]
35. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.
Umeda Y; Taniguchi S; Arima K; Piao YS; Takahashi H; Iwatsubo T; Mann D; Hasegawa M
Neurosci Lett; 2004 Apr; 359(3):151-4. PubMed ID: 15050686
[TBL] [Abstract][Full Text] [Related]
36. DEAD-box helicase eIF4A2 inhibits CNOT7 deadenylation activity.
Meijer HA; Schmidt T; Gillen SL; Langlais C; Jukes-Jones R; de Moor CH; Cain K; Wilczynska A; Bushell M
Nucleic Acids Res; 2019 Sep; 47(15):8224-8238. PubMed ID: 31180491
[TBL] [Abstract][Full Text] [Related]
37. Tau protein as a differential biomarker of tauopathies.
Sergeant N; Delacourte A; Buée L
Biochim Biophys Acta; 2005 Jan; 1739(2-3):179-97. PubMed ID: 15615637
[TBL] [Abstract][Full Text] [Related]
38. DDX6 is a positive regulator of Ataxin-2/PAPD4 cytoplasmic polyadenylation machinery.
Inagaki H; Hosoda N; Hoshino SI
Biochem Biophys Res Commun; 2021 May; 553():9-16. PubMed ID: 33756349
[TBL] [Abstract][Full Text] [Related]
39. Threonine
Moszczynski AJ; Yang W; Hammond R; Ang LC; Strong MJ
Acta Neuropathol Commun; 2017 Jan; 5(1):6. PubMed ID: 28077166
[TBL] [Abstract][Full Text] [Related]
40. Intercellular transfer of tau aggregates and spreading of tau pathology: Implications for therapeutic strategies.
Clavaguera F; Grueninger F; Tolnay M
Neuropharmacology; 2014 Jan; 76 Pt A():9-15. PubMed ID: 24050961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
